课题基金 / 基金详情

Molecular biology of vasoactive substances

Molecular biology of vasoactive substances
血管活性物质的分子生物学
批准号:
06044129
负责人:
NAKAO Kazuwa
金额:
$2.82万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for international Scientific Research
财政年份:
1994
资助国家:
日本
项目状态:
已结题
起止时间:
1994 至 1995

项目摘要

项目成果

NAKAO Kazuwa的其他基金

相似基金

相关文献

中文摘要
翻译
在体外培养的新生大鼠心肌细胞肥大模型中,脑利钠肽(BNP)mRNA表达增加,并在1h内达到最高水平,该作用可被转录抑制剂完全抑制。当富含CT的序列(-1288~-1095)被删除时,克隆的人BNP基因5‘侧翼区的启动子活性降低到30%。RT-PCR检测到两个新的人内皮素-A受体(ET-AR)基因转录本,分别含有199和327个碱基的缺失,缺失的序列分别对应于外显子4和外显子3和4,表明这两个ET-AR转录本是由RNA选择性剪接产生的。该负调控区位于小鼠血管紧张素Ⅱ2型受体基因-453~-225之间,其中含有干扰素调节因子(IRF)结合基序。IRF-2抑制生长和融合细胞中AT2受体的表达,而IRF-1仅增强融合细胞中AT2受体的表达。人前列环素受体基因全长约7.0kb,由3个外显子组成,定位于19号染色体,转录起始点位于ATG起始密码子上游870~872bp。1.2kb的5‘侧翼区缺少传统的TATA和CCAAT盒,但它含有几个顺式作用调控元件,包括一个倒置的CCAAT盒和两个SP-1结合位点的拷贝。
英文摘要
Brain natriuretic peptide (BNP) mRNA increased and reached a maximal level within 1 h in a model of cardiac hypertrophy using cultured neonatal ratventricular cardiocytes, which was completely diminished by a transcriptional inhibitor. The promotor activity of the cloned 5'-flanking region of human BNP gene was reduced to 30% when the CT-rich sequences (-1288 to -1095) were deleted. The BNP gene was assigned to human chromosome 1. Two novel transcripts of the human endothelin-A receptor (ET-AR) gene contained deletions of 199 bp and 327 bp were demonstrated using RT-PCR.The deleted sequences corresponded to exon 4 and exons 3 and 4, respectively, indicating these ET-AR transcripts result from alternative RNA splicing. The putative negative regulatory region was located between -453 and -225 of mouse angiotensin II type 2 (AT_2) receptor gene, in which the interferon regulatory factor (IRF) binding motif was identified. IRF-2 attenuated the AT2 receptor expression in both growing and confluent R3T3 cells, whereas IRF-1 enhanced AT2 receptor expression in the confluent cells only. The human prostacyclin receptor gene spanned approximately 7.0 kb and was composed of three exons, which was assigned to chromosome 19. The transcription initiation sites were mapped 870-872 bp upstream to the ATG start codon. The 1.2-kb 5'-flanking region lacked conventional TATA and CCAAT boxes, but it contained several cis-acting regulatory elements including an inverted CCAAT box and two copies of SP-1 binding sites.
期刊论文(26)
专著(0)
科研奖励(0)
会议论文
Y.Miyamoto, T.Yoshimasa, H.Arai, K.Takaya, Y.Ogawa, H.Itoh, K.Nakao: "Alternative RNA splicing of human endothelin-A receptor generates multiple transcripts." Biochemical J.313. 795-801 (1996)
Y.Miyamoto、T.Yoshimasa、H.Arai、K.Takaya、Y.Okawa、H.Itoh、K.Nakao:“人内皮素 A 受体的选择性 RNA 剪接会生成多个转录本。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
M.Mukoyama,M.Horiuchi,M.Nakajima,R.E.Prattt,V.J.Dzau: "Characterization of a rat type 2 angiotensin II receptor stably expressed in 293 cells." Mol.Cell.Endocrinol.112. 61-68 (1995)
M.Mukoyama、M.Horiuchi、M.Nakajima、R.E.Prattt、V.J.Dzau:“在 293 细胞中稳定表达的大鼠 2 型血管紧张素 II 受体的表征。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
M.Horiuchi, G.Koike, T.Yamada, M.Mukoyama, M.Nakajima, V.J.Dzau: "The growth-dependent expression of angiotensin II type 2 receptor is regulated by transcription factors interferon regulatory factor-1 and -2." J.Biol.Chemist.270. 20225-20230 (1995)
M.Horiuchi、G.Koike、T.Yamada、M.Mukoyama、M.Nakajima、V.J.Dzau:“血管紧张素 II 2 型受体的生长依赖性表达受转录因子干扰素调节因子-1 和 -2 的调节。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
O.Nakagawa et al.: "Molecular cloning of human prostacyclin receptor cDNA and its gene expression on cardiovascular system." Circulation. 90. 1643-1647 (1994)
O.Nakakawa 等人:“人前列环素受体 cDNA 的分子克隆及其对心血管系统的基因表达”。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 24 条
    Development and analysis of model rats for diseases of endocrinology and metabolism
    • 批准号:
      23659476
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2011
    • 负责人:
      NAKAO Kazuwa
    • 依托单位:
    Physiological Function of Hormones Derived from Mesenchymal Cells and Its Failure
    • 批准号:
      21229013
    • 项目类别:
      Grant-in-Aid for Scientific Research (S)
    • 资助金额:
      $135.62万
    • 财政年份:
      2009
    • 负责人:
      NAKAO Kazuwa
    • 依托单位:
    Translational research and development of novel diagnostic/therapeutic modalities for metabolic syndrome based on adipocyte endocrinology and adiposcience
    • 批准号:
      16109007
    • 项目类别:
      Grant-in-Aid for Scientific Research (S)
    • 资助金额:
      $73.22万
    • 财政年份:
      2004
    • 负责人:
      NAKAO Kazuwa
    • 依托单位:
    Molecular Basis of Centrally-controled Energy Homeostasis -Focusing on Leptin Resistance-
    • 批准号:
      13307033
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $35.36万
    • 财政年份:
      2001
    • 负责人:
      NAKAO Kazuwa
    • 依托单位:
    海外基金